Showing results 5 to 11 of 11
< previous
Issue Date | Title | Author(s) |
2015 | The need for a marker predicting benefit following cardiovascular disease risk reduction treatment | Konig, CS; Atherton, M; Rogers, N; Gomm, C; Bailey, C; Strange, RC; Shipman, K; Haliday, I; Levya, F; Ramachandran, S |
2017 | A pilot study to assess peak systolic velocity as a possible marker of atherosclerotic burden using ultrasound | Koenig, C; Atherton, M; Cavazutti, M; Ramachandran, S; Gomm, C; Strange, R |
12-Mar-2021 | The possible association of peak systolic velocity in the carotid artery with coronary heart disease – a study based on portable ultrasound | Koenig, CS; Atherton, M; Cavazzuti, M; Gomm, C; Ramachandran, S |
23-Sep-2021 | Testosterone Therapy in Adult-Onset Testosterone Deficiency: Hematocrit and Hemoglobin Changes | Lorde, N; Maarouf, A; Strange, RC; König, CS; Hackett, G; Haider, A; Haider, KS; Desnerck, P; Saad, F; Ramachandran, S |
26-Mar-2019 | Testosterone Therapy: An Assessment of the Clinical Consequences of Changes in Hematocrit and Blood Flow Characteristics | König, CS; Balabani, S; Hackett, GI; Strange, RC; Ramachandran, S |
9-Nov-2021 | Testosterone Therapy: Increase in Hematocrit is Associated with Decreased Mortality | Strange, RC; König, CS; Ahmed, A; Hackett, G; Haider, A; Haider, KS; Desnerck, P; Saad, F; Lorde, N; Maarouf, A; Ramachandran, S |
2013 | The thermodynamics of metabolism, cardiovascular performance and exercise, in health and diabetes: The objective of clinical markers | König, CS; Ramachandran, S; González-Alonso, J; Atherton, MA; Collins, MW |